BioAdaptives, Inc.
BDPT
$0.0257
$0.00124.90%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.20K | -- | 0.00 | -- | 700.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.20K | -- | 0.00 | -- | 700.00 |
| Cost of Revenue | 2.20K | -- | 0.00 | 60.00K | 21.60K |
| Gross Profit | 1.10K | -- | 0.00 | -60.00K | -20.90K |
| SG&A Expenses | 279.30K | 249.10K | 337.30K | 61.90K | 54.10K |
| Depreciation & Amortization | 1.00K | -- | 0.00 | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 282.40K | 249.10K | 337.30K | 121.90K | 75.70K |
| Operating Income | -279.20K | -249.10K | -337.30K | -121.90K | -75.00K |
| Income Before Tax | -157.90K | -197.10K | -371.80K | -37.60K | -183.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -157.90K | -197.10K | -371.80K | -37.60K | -183.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -157.90K | -197.10K | -371.80K | -37.60K | -183.00K |
| EBIT | -279.20K | -249.10K | -337.30K | -121.90K | -75.00K |
| EBITDA | -278.70K | -248.70K | -337.30K | -121.90K | -75.00K |
| EPS Basic | -0.02 | -0.02 | -0.04 | -0.01 | -0.06 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | 0.00 | -0.03 |
| EPS Diluted | -0.02 | -0.02 | -0.04 | -0.01 | -0.06 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | 0.00 | -0.03 |
| Average Basic Shares Outstanding | 9.53M | 9.05M | 9.91M | 5.97M | 2.99M |
| Average Diluted Shares Outstanding | 9.53M | 9.05M | 9.91M | 5.97M | 2.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |